1. Home
  2. RYZB

RYZB

RayzeBio Inc.

Logo RayzeBio Inc.

as 03-07-2024 9:35am EST

$
-
-
.
-
-
-
$
-
.
-
-
-
.
-
-
%

RayzeBio inc is a company operating as vertically integrated radiopharmaceutical therapeutics company. The main objective of the company is defeating cancer with radiopharmaceutical medicines. It has a created a pipeline of multiple drug candidates, in therapeutic areas with significant market opportunities. They have a portfolio of potential RPT drug and development candidates that includes late-stage clinical programs, development programs and discovery programs.

Founded: 2020 Country:
United States
United States
Employees: 88 City: SAN DIEGO
Market Cap: 3.8B IPO Year: 2023
Target Price: $31.33 AVG Volume (30 days): 745.5K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.08 EPS Growth: N/A
52 Week Low/High: $17.95 - $62.51 Next Earning Date: 03-05-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: